Cerus Corporation (NasdaqGM: CERS)
Health Care · Health Care Equipment & Supplies · US
$2.69
-4.27% today · +122.1% 1Y
Cerus Corporation (NasdaqGM: CERS) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $566.28M and employs 268 people.
Over the last twelve months the share price has gained 122.1%, trading between 1.17 and 3.47.
Tweenvest scores Cerus Corporation across four factors: quality 51/100, value 43/100, growth 75/100. Its strongest factor is growth.
CERS price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $566.28M
- Revenue (TTM)
- $221.55M
- P/E
- —
- EPS
- -0.03
- Dividend yield
- —
- Beta (5Y)
- 1.77
- 52-week high
- $3.47
- 52-week low
- $1.17
- Avg volume (3M)
- —
- Shares outstanding
- 201.52M
- Employees
- 268
- Next earnings
- —
About Cerus Corporation
Cerus Corporation operates as a biotechnology firm dedicated to advancing and marketing the INTERCEPT Blood System. This proprietary technology significantly enhances the safety of transfusable blood components by neutralizing biological threats, thereby reducing the risk of blood-borne pathogens. The company's product line includes INTERCEPT systems specifically engineered to deactivate pathogens in donated platelets and plasma. It also offers a dedicated INTERCEPT Blood System for the inactivation of harmful agents in red blood cell components. Furthermore, Cerus markets an INTERCEPT Blood System for Cryoprecipitation, which leverages its plasma technology to produce two key pathogen-reduced blood products: a cryoprecipitated fibrinogen complex for treating and controlling bleeding, particularly massive hemorrhages stemming from fibrinogen deficiency, and pathogen-reduced, cryoprecipitate-reduced plasma. Cerus distributes these platelet and plasma systems globally through a combination of its direct sales force and an extensive network of distributors, reaching markets in North America, Europe, the Commonwealth of Independent States, the Middle East, and Latin America. Established in 1991, Cerus Corporation maintains its corporate headquarters in Concord, California.
- ISIN
- US1570851014
- Founded
- 1991
- Listed since
- Jan 31, 1997
- Exchange
- Nasdaq Global Market
- Currency
- USD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Abbott LaboratoriesNYSE: ABT | $201.88B | $116.67 | +0.03% |
| Intuitive Surgical, Inc.NasdaqGS: ISRG | $131.97B | $373.57 | -1.38% |
| Stryker CorporationNYSE: SYK | $125.74B | $327.81 | -0.50% |
| Medtronic plcNYSE: MDT | $118.91B | $92.90 | -0.48% |
| EssilorLuxottica Société anonymeENXTPA: EL | $86.72B | €161.70 | -0.92% |
| Boston Scientific CorporationNYSE: BSX | $71.03B | $49.01 | -2.70% |
| Siemens Healthineers AGXTRA: SHL | $52.46B | €40.39 | +0.47% |
| HOYA CorporationTSE: 7741 | $52.35B | ¥24,895.00 | -1.37% |
Figures last refreshed Aug 18, 2026.